Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR88 | Q9GZN0 | 2/20 | 0.42 |
| ▸ | FNTA | P49354 | 6/20 | 0.41 |
| ▸ | FNTB | P49356 | 6/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.40 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.39 |
| ▸ | FDPS | P14324 | 2/20 | 0.39 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21523097 | 1.00 | GPR88 (0.42) | GPR88FNTAFNTBTRPV1GGPS1 | |
| SCHEMBL21523096 | 1.00 | GPR88 (0.42) | GPR88FNTAFNTBTRPV1GGPS1 | |
| SCHEMBL21523094 | 1.00 | GPR88 (0.42) | GPR88FNTAFNTBTRPV1GGPS1 | |
| SCHEMBL21531592 | 0.86 | TRPV1 (0.43) | FNTAFNTBTRPV1GGPS1FDPS | |
| Hydrochloric Acid SCHEMBL21523065 | 0.85 | TRPV1 (0.42) | FNTAFNTBTRPV1GGPS1FDPS | |
| SCHEMBL21523036 | 0.83 | TRPV1 (0.45) | FNTAFNTBTRPV1GGPS1FDPS | |
| SCHEMBL21523035 | 0.83 | TRPV1 (0.45) | FNTAFNTBTRPV1GGPS1FDPS | |
| SCHEMBL21531581 | 0.82 | TRPV1 (0.42) | FNTAFNTBTRPV1GGPS1FDPS | |
| Hydrochloric Acid SCHEMBL21523078 | 0.78 | TRPV1 (0.38) | FNTAFNTBTRPV1GGPS1FDPS | |
| Hydrochloric Acid SCHEMBL21523102 | 0.77 | TRPV1 (0.54) | FNTATRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190330141-A1 | Compositions With A Cooling Effect | THE PROCTER & GAMBLE COMPANY | 2019-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190330141-A1 | Compositions With A Cooling Effect | CUTA, FABP4, EBP | GPR88 733/4885FNTA 4661/4885FNTB 4823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.